ZNTL
Zentalis Pharmaceuticals Llc
2.60$
-4.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.2% | 88.4% | 90.4% | 89.4% | 88.8% | 89.7% | 89.3% | 88.6% | 88.1% | 87.6% | 86.2% | 84.2% | |
| 18.9% | 5.0% | 6.7% | 7.5% | 9.2% | 7.9% | 10.9% | 10.7% | 11.9% | 12.5% | 12.6% | 11.5% | |
| 88.2% | 85.9% | 87.7% | 86.7% | 86.8% | 86.2% | 86.6% | 86.3% | 85.8% | 85.1% | 83.7% | 81.1% | |
| 0.5% | – | – | – | – | 1.2% | – | 0.7% | – | 0.7% | – | 0.8% | |
| 1.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 0.6% | 0.7% | 0.7% | 0.8% | 0.8% | 0.0% | – | – | – | – | – | – | |
| 17.7% | 22.2% | 17.7% | 22.2% | 21.4% | 21.6% | 23.1% | 22.0% | 22.7% | 25.2% | 27.8% | 33.3% | |
| 10.1% | 12.3% | 9.8% | 13.6% | 12.2% | 12.3% | 12.9% | 11.1% | 11.4% | 12.7% | 13.9% | 17.5% | |
| 0.4% | 0.5% | 0.5% | 0.6% | 0.6% | 0.7% | 0.9% | 1.0% | 1.1% | 1.3% | 1.6% | 1.9% | |
| 2.4% | 2.7% | 1.9% | 4.2% | 1.8% | 1.7% | 2.0% | 1.1% | 2.1% | 2.5% | 2.9% | 3.8% | |
| 82.3% | 77.8% | 82.3% | 77.8% | 78.6% | 78.4% | 76.9% | 78.0% | 77.3% | 74.8% | 72.2% | 66.7% | |
| -141.3% | -158.1% | -157.6% | -196.6% | -223.4% | -245.0% | -287.1% | -321.2% | -353.3% | -412.3% | -484.8% | -589.4% | |
| 12.1% | 12.6% | 12.8% | 14.4% | 15.8% | 16.6% | 18.7% | 20.5% | 22.0% | 24.8% | 27.8% | 32.6% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.